✦ LIBER ✦

‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC)

✍ Scribed by William Pao; Vincent A. Miller; Mark G. Kris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus synergizes with gefitinib in

✍ Dong, Song; Zhang, Xu-Chao; Cheng, Hua; Zhu, Jian-Quan; Chen, Zhi-Hong; Zhang, Y 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 753 KB

Mutations in the Epidermal Growth Factor

✍ G. Kesava Reddy; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 73 KB

Epidermal growth factor receptor targete

✍ Cappuzzo, Federico; Ardizzoni, Andrea; Soto-Parra, Hector; Gridelli, Cesare; Mai 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 270 KB

PD-150 Gefitinib (Iressa)-sensitive muta

✍ Mu, X.; Li, L.; Zhang, X.; Wang, M.; Feng, R.; Cui, Q.; Zhou, H.; Guo, B. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Mutations in the Tyrosine Kinase Domain

✍ Yang, S. H. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 134 KB

Gefitinib (‘Iressa’), an epidermal growt

✍ Satoru Shintani; Chunnan Li; Mariko Mihara; Koh-ichi Nakashiro; Hiroyuki Hamakaw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 239 KB